Apollo Hospitals Enterprise Ltd traded at 7,724.50 this Friday March 6th, decreasing 50.50 or 0.65 percent since the previous trading session. Looking back, over the last four weeks, Apollo Hospitals Enterprise Ltd lost 7.12 percent. Over the last 12 months, its price rose by 24.27 percent. Looking ahead, we forecast Apollo Hospitals Enterprise Ltd to be priced at 7,571.57 by the end of this quarter and at 7,145.95 in one year, according to Trading Economics global macro models projections and analysts expectations.
Apollo Hospitals Enterprise Limited is an India-based integrated healthcare company. The Company is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. The Company''s segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. It is engaged in hospitals and hospitals-based services. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 beds across 73 hospitals, 6000 pharmacies and 2500 clinics and diagnostic centers, as well as 500 telemedicine centers.